Related Experiment Videos
Pharmacology for renal calculi
1Portsmouth Naval Hospital, Portsmouth, Virginia, USA.
Expert Opinion on Pharmacotherapy
|March 16, 2001
Summary
This review details pharmacologic management for urinary calculi, focusing on stone type. Key recommendations include increased fluid intake and dietary modifications for all patients with kidney stones.
Area of Science:
- Nephrology
- Urology
- Pharmacology
Background:
- Urinary stone disease (calculi) remains a significant health issue despite diagnostic and therapeutic advancements.
- Effective management strategies are crucial to reduce patient morbidity.
Purpose of the Study:
- To summarize current pharmacologic treatments for urinary calculi, categorized by stone type.
- To provide an overview of therapeutic agents and their applications.
Main Methods:
- Literature review of pharmacologic management strategies for different types of urinary stones.
- Analysis of current treatment guidelines and available therapeutic agents.
Main Results:
- General advice for all stone patients: increase fluid intake, limit dietary protein and sodium.
- Specific agents for calcium oxalate stones: sodium cellulose phosphate, thiazides, orthophosphates, calcium supplements, pyridoxine, cholestyramine, citrate, magnesium, and allopurinol.
- Management of struvite and cystine stones involves addressing underlying causes and specific medications like urease inhibitors and agents such as D-Penicillamine, captopril, and alpha-mercaptopropionylglycine (MPG).
Conclusions:
- Pharmacologic management of urinary calculi is tailored to the specific stone composition.
- Continued research, including randomized trials and understanding of stone inhibitors, will further refine medical management strategies.